Efficacy and safety of Isavuconazole for the treatment of invasive Aspergillus infection - an update of the literature

• Published in: Expert opinion on pharmacotherapy Vol. 23; no. 5; p. 543
• Main Authors: Sivasubramanian, Geetha, Chandrasekar, Pranatharthi H
• Format: Journal Article
• Language: English
• Published: England 24.03.2022
• Subjects: Antifungal Agents - adverse effects; Aspergillosis - chemically induced; Aspergillosis - drug therapy; COVID-19 - drug therapy; Delayed Diagnosis; Humans; Nitriles - adverse effects; Pyridines; Triazoles - adverse effects; isavuconazole; Invasive aspergillosis; aspergillus

Invasive aspergillosis is associated with high morbidity and mortality in immunocompromised patients. It is now increasingly reported in critically ill patients, including those with respiratory viral infections, such as influenza and COVID-19. Antifungal management is challenging due to diagnostic...